Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA alleles modulate EBV viral load in multiple sclerosis
Simone Agostini, Roberta Mancuso, Franca Rosa Guerini, et al.
Journal of Translational Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Epstein–Barr virus and multiple sclerosis
Samantha S. Soldan, Paul M. Lieberman
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 51-64
Open Access | Times Cited: 296
Environmental and genetic risk factors for MS: an integrated review
Emmanuelle Waubant, Robyn Lucas, Ellen M. Mowry, et al.
Annals of Clinical and Translational Neurology (2019) Vol. 6, Iss. 9, pp. 1905-1922
Open Access | Times Cited: 265
How Does the Immune System Enter the Brain?
Josephine A. Mapunda, Houyam Tibar, W. Regragui, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 100
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Epstein–Barr virus as a potentiator of autoimmune diseases
William H. Robinson, Shady Younis, Zelda Z. Love, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 729-740
Closed Access | Times Cited: 20
Genetic and epigenetic factors associated with increased severity of Covid‐19
Zafer Yildirim, Oyku Semahat Sahin, Seyhan Yazar, et al.
Cell Biology International (2021) Vol. 45, Iss. 6, pp. 1158-1174
Open Access | Times Cited: 66
Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection
Anna Karin Hedström
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis
Jesse Huang, Katarina Tengvall, Izaura Bomfim Lima, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3573-3582
Open Access | Times Cited: 9
High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk
Anna Karin Hedström, Jesse Huang, Angelica Michel, et al.
Frontiers in Neurology (2020) Vol. 10
Open Access | Times Cited: 62
Lifestyle-based Modifiable Risk Factors in Multiple Sclerosis: Review of Experimental and Clinical Findings
Dejan Jakimovski, Yi Guan, Murali Ramanathan, et al.
Neurodegenerative Disease Management (2019) Vol. 9, Iss. 3, pp. 149-172
Closed Access | Times Cited: 59
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System
Oluf Andersen, Ingemar Ernberg, Anna Karin Hedström
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 4599-4620
Open Access | Times Cited: 17
Role of environmental factors in multiple sclerosis
Amin Zarghami, Ying Li, Suzi B. Claflin, et al.
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 12, pp. 1389-1408
Closed Access | Times Cited: 37
Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis
David Baker, Gareth Pryce, Sandra Amor, et al.
Brain (2018) Vol. 141, Iss. 10, pp. 2834-2847
Open Access | Times Cited: 46
Epstein-Barr virus infection in the development of neurological disorders
Samantha S. Soldan, Paul M. Lieberman
Drug Discovery Today Disease Models (2020) Vol. 32, pp. 35-52
Open Access | Times Cited: 38
Epstein-Barr Virus in the Cerebrospinal Fluid and Blood Compartments of Patients With Multiple Sclerosis and Controls
Joonas Lehikoinen, Katariina Nurmi, Mari Ainola, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 3
Closed Access | Times Cited: 4
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation
Tilman Schneider‐Hohendorf, Christian Wünsch, Simon Falk, et al.
Brain (2024)
Closed Access | Times Cited: 4
Exploring the Role of KIR2DS4 and HLA-A*02:07 in Predicting Chemotherapy Sensitivity and Erythrocytopenia in Nasopharyngeal Carcinoma
J. Ye, Haitao Ma, Xue-Meng Jiang, et al.
Research Square (Research Square) (2025)
Open Access
Human Herpesvirus 6A Is a Risk Factor for Multiple Sclerosis
Wangko Lundström, Rasmus Gustafsson
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
CD4 T cells restricted to DRB1*15:01 recognize two Epstein–Barr virus glycoproteins capable of intracellular antigen presentation
Natalia Drosu, Monique Anderson, Philippe‐Antoine Bilodeau, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 44
Closed Access | Times Cited: 3
HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis
Ranjan Ramasamy, Fiyaz Mohammed, Ute-C. Meier
Immunology Letters (2019) Vol. 217, pp. 15-24
Open Access | Times Cited: 24
Smoking and Epstein–Barr virus infection in multiple sclerosis development
Anna Karin Hedström, Jesse Huang, Nicole Brenner, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Epstein-Barr Virus Load Correlates with Multiple Sclerosis-Associated Retrovirus Envelope Expression
Silvia Pérez‐Pérez, María Inmaculada Domínguez‐Mozo, Maria Ángel García‐Martínez, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 387-387
Open Access | Times Cited: 14
Epstein–Barr virus and genetic risk variants as determinants of T-bet+ B cell-driven autoimmune diseases
Laurens Bogers, Kirsten L. Kuiper, Joost Smolders, et al.
Immunology Letters (2023) Vol. 261, pp. 66-74
Open Access | Times Cited: 7
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis
Ellen F. Mosleth, Christian A. Vedeler, Kristian Hovde Liland, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study
María Inmaculada Domínguez‐Mozo, Lorena López-Lozano, Silvia Pérez‐Pérez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top